Both in Pharmaceuticals
Xeris Biopharma Holdings vs Septerna
Over the past year XERS returned +23.5% and SEPN returned +115.6%; their daily moves had a correlation of 0.19.
XERS +23.5% SEPN +115.6%Growth of $1, one year, split-adjusted
| Metric | XERS | SEPN |
|---|---|---|
| Price | $9.98 | $39.13 |
| Market cap | $1.82B | $1.83B |
| Today | +1.53% | −1.53% |
| 1 month | +17.7% | +0.6% |
| 6 months | +78.2% | +67.9% |
| Year to date | +27.1% | +40.4% |
| 1 year | +22.0% | +124.2% |
| Revenue growth (YoY) | +28.7% | +22375.6% |
| Gross margin | 86.4% | 100.0% |
| Net margin | −33.8% | −48.7% |
| P/E (TTM) | — | — |
| Price / sales | 5.4× | 18.5× |
| Net cash | -$130.8M | $372.3M |
| Dividend yield | — | — |
| Volatility (60d) | 51.6% | 67.2% |
| Short % of float | 4.6% | 9.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).